Description
The Ovarian Cancer Research Program (OCRP) is soliciting applications for the Clinical Trial Award, which supports the rapid implementation of clinical trials with the potential to significantly impact ovarian cancer treatment or management. Proposed projects may range from small, proof-of-concept trials to large-scale, definitive trials. Applications require preliminary data and must demonstrate the potential to make an important contribution to ovarian cancer or patient/survivor care. Key features of the award include:
• Maximum period of performance: 4 years
• Maximum allowable funding: $2.8 million for total costs
• Eligibility: Independent investigators at all academic levels
• Submission deadline: October 1, 2026
• Requires a Letter of Intent prior to full application submission
The goal of the Clinical Trial Award is to support high-impact research that addresses a critical need and demonstrates the potential to make an important contribution to ovarian cancer or patient/survivor care.